CHEETAH MEDICAL PARTNERS WITH SEPSIS ALLIANCE TO SUPPORT HEALTHCARE PROVIDER EDUCATION ON SEPSIS – THE THIRD LEADING CAUSE OF DEATH IN THE UNITED STATES
Cheetah Medical provides unrestricted educational support for Sepsis Alliance’s Fluid Resuscitation and Sepsis webinar and sponsors the 8th Annual Sepsis Heroes gala.
San Diego, Calif, March 25, 2019 – Sepsis Alliance, the nation’s leading sepsis organization, and Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management, today announced their partnership to improve outcomes for sepsis patients through support of healthcare provider education. Sepsis is the body’s life-threatening response to infection that affects 1.7 million people in the United States each year.
Cheetah Medical is providing unrestricted educational support for Sepsis Alliance’s March 28, 2019, webinar, Fluid Resuscitation and Sepsis. This webinar will review evidence-based fluid management strategies for adult and pediatric patients with sepsis and septic shock. It is part of Sepsis Alliance’s Sepsis: Across the Continuum of Care Webinar Series. This series provides education on sepsis and related topics for healthcare providers across the entire continuum of care, from critical care to home care staff.
“Through our partnership with Cheetah Medical we are able to continue educating healthcare providers about appropriate and life-saving treatments for sepsis, which is the leading cause of death in U.S. hospitals,” said Thomas Heymann.
Cheetah Medical is also a sponsor of Sepsis Alliance’s 8th Annual Sepsis Heroes gala, which will take place on September 12, 2019, in New York City, NY. This annual event, timed to coincide with Sepsis Awareness Month, honors Sepsis Heroes who have made a significant contribution to sepsis awareness and education among both the general public and healthcare professionals.
“Cheetah is proud to be associated with the Sepsis Alliance. Their efforts to raise awareness of the importance of early identification and appropriate treatment of Sepsis can improve clinical outcomes for millions of people worldwide,” said Chris Hutchison, CEO of Cheetah Medical.
To learn more about the upcoming March 28, 2019, Fluid Resuscitation and Sepsis webinar, and the entire Sepsis: Across the Continuum of Care Webinar Series, please visit www.sepsiswebinar.org. For information about the 8th Annual Sepsis Heroes gala, please visit www.sepsisheroes.org.
Unless clearly marked as sponsor-presented content, it is Sepsis Alliance’s policy that funders and sponsors may not contribute to or influence the health information or any other content of the Sepsis Alliance website, or any Sepsis Alliance communication, including webinars. For more information on Sepsis Alliance’s funding and sponsorship policy, please visit www.sepsis.org/about/funding-and-sponsorship-policy/.
About Sepsis Alliance:
Sepsis Alliance is the leading sepsis organization in the U.S., working in all 50 states to save lives and reduce suffering by raising awareness of sepsis as a medical emergency. In 2011, Sepsis Alliance designated September as Sepsis Awareness Month to bring healthcare professionals and community members together in the fight against sepsis. In 2018, Sepsis Alliance created the award-winning national campaign, It’s About T.I.M.E.TM, to educate the public about the signs and symptoms of sepsis and to highlight the urgent need to seek treatment when symptoms are recognized. Sepsis Alliance gives a voice to the millions of people who have been touched by sepsis – to the survivors, and the friends and family members of those who have survived or who have died. Since 2007, sepsis awareness in the U.S. has risen from 19% to 65%. Sepsis Alliance is a GuideStar Gold Rated charity. For more information, please visit www.sepsis.org. Connect with us on Facebook and Twitter at @SepsisAlliance.
About Cheetah Medical:
Cheetah Medical is the pioneer and leading global provider of 100 percent non-invasive fluid management monitoring technologies, designed for use in critical care, operating room and emergency department settings. The CHEETAH Starling™ SV is fast becoming the gold standard in fluid management, as it provides immediate, dynamic assessments of fluid responsiveness, enabling clinicians to make more confident and informed treatment for their patients. Moreover, recent research from the University of Kansas Medical Center has shown effective fluid management can reduce hospital ICU stays by an average of 2.89 days, reduce risk of mechanical ventilation and initiation of acute dialysis, saving over $14,000 in medical costs per patient. The company’s fluid management systems currently make an impact in more than 400 hospitals throughout the U.S. and in 30 countries worldwide.
Could HighCape be the right partner for your growing business?
Contact us for more information.
452 5th Ave, 21st Floor
New York, NY 10018